American Society of Hirudotherapy

Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications

Research article published in Journal of medicinal chemistry (2010)

Last Updated: March 18, 2026Reviewed by: ASH Editorial Board
Drug DevelopmentClinical TrialsCorral-Rodríguez M et al. · Journal of medicinal chemistry, 2010

Summary

Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications.

Why This Matters for Hirudotherapy

Relevant to the development and clinical application of leech-derived pharmaceutical compounds.

Citation

Leech-derived thrombin inhibitors: from structures to mechanisms to clinical applications.

Corral-Rodríguez M et al. · Journal of medicinal chemistry, 2010

DOI

Added to ASH library: March 18, 2026 · Site last updated: March 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.